We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Acetaminophen-Related Liver Failure

By HospiMedica staff writers
Posted on 14 Dec 2005
Acetaminophen poisoning has become the most common cause of acute liver failure in the United States. More...
While attempted suicides still account for many cases, almost half are the result of unintentional overdose.

Acetaminophen is also the most widely used pain reliever in the United States--6% of Americans ingest it at least once a month--but taking more than the recommended dose can lead to fatal liver injury. While intentional overdoses generally present early after ingestion and can be treated with N-acetylcysteine, unintentional overdoses are usually not recognized until later.

As a result, University of Washington (Seattle, WA, USA) researchers suspected that patients with acute liver failure from unintentional acetaminophen overdoses would have more severe disease and worse outcomes than patients with intentional overdoses.

The researchers conducted a prospective study of patients presenting with acute liver disease to any of 22 academic centers participating in the acute liver failure study group, over a six-year period between 1998 and 2003. Of those diagnosed with acetaminophen-related acute liver failure, 44% had intentionally overdosed on the drug in suicide attempts and 48% had overdosed unintentionally.

Those who had unintentionally overdosed were older, used multiple acetaminophen-containing medications more frequently, and waited longer to seek care after their symptoms began. Most reported that they had been taking the medications specifically for pain. They were more likely to have severe hepatic encephalopathy than patients who had overdosed intentionally.

"Our data suggest that there is a narrow therapeutic margin and that consistent use of as little as 7.5 g/day may be hazardous,” the authors reported. Their data also suggest that there is no chronic form of acetaminophen injury, rather, a threshold of safety that, when breached, has devastating results.

The study was published in the December 2005 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).




Related Links:
U. of Washington

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.